NHPAP Company Profile and Key Details

The stock is currently trading near its 52-week high $17.18 and $25.25. With a market capitalization of about $714.65 million, National Healthcare Properties, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.55). Key stats such as the average daily volume over the past year has been around 19.09 thousand shares, volume is running light vs its 52-week average. Headquartered in Newport, NY, National Healthcare Properties, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Michael R. Anderson, the company employs approximately 26 people and listed since December 09, 2019. National Healthcare Properties, Inc. functions as a real estate investment trust, with its activities centered on Medical Office Buildings and Senior Housing Operating Properties.

National Healthcare Properties, Inc. earnings surprise history is a mixed track record. The quarter that ended August 05, 2026, missed forecasts by 13.04%. The prior quarter beat by 134.78%. Over the last six quarters, Apple has recorded several small beats. These include 134.78% in May 13, 2026.

Average 10-day trading volume of 13.70 thousand shares is below the 3-month average of 19.13 thousand, indicating normal recent market interest.

National Healthcare Properties, Inc. last paid a dividend of 1.84 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$16.80. This means the shares are trading below this model’s fair value.

Valuation shows National Healthcare Properties, Inc. trading at a premium to the broader market with a P/E of -13.43.

Our AI price prediction model suggests that National Healthcare Properties, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

National Healthcare Properties, Inc. trades at a P/E ratio of -13.43, slightly below the S&P 500 average, with a price-to-sales ratio of 2.08 and a price-to-book ratio of 1.47 suggesting the stock is closer to book value. The P/FCF stands at 30.06, also above market averages.